title: The Bristol third stage trial: active versus physiological management of third stage of labour.
abstract: OBJECTIVE
  To compare the effects on fetal and maternal morbidity of routine active management of third stage of labour and expectant (physiological) management, in particular to determine whether active management reduced incidence of postpartum haemorrhage.
  
  
  METHODS
  Randomised trial of active versus physiological management. Women entered trial on admission to labour ward with allocation revealed just before vaginal delivery. Five months into trial high rate of postpartum haemorrhage in physiological group (16.5% v 3.8%) prompted modification of protocol to exclude more women and allow those allocated to physiological group who needed some active management to be switched to fully active management. Sample size of 3900 was planned, but even after protocol modification a planned interim analysis after first 1500 deliveries showed continuing high postpartum haemorrhage rate in physiological group and study was stopped.
  
  
  METHODS
  Maternity hospital.
  
  
  METHODS
  Of 4709 women delivered from 1 January 1986 to 31 January 1987, 1695 were admitted to trial and allocated randomly to physiological (849) or active (846) management. Reasons for exclusion were: refusal, antepartum haemorrhage, cardiac disease, breech presentation, multiple pregnancy, intrauterine death, and, after May 1986, ritodrine given two hours before delivery, anticoagulant treatment, and any condition needing a particular management of third stage.
  
  
  METHODS
  All but six women allocated to active management actually received it, having prophylactic oxytocic, cord clamping before placental delivery, and cord traction; whereas just under half those allocated to physiological management achieved it. A fifth of physiological group received prophylactic oxytocic, two fifths underwent cord traction and just over half clamping of the cord before placental delivery.
  
  
  METHODS
  Reduction in incidence of postpartum haemorrhage from 7.5% under physiological management to 5.0% under active management.
  
  
  RESULTS
  Incidence of postpartum haemorrhage was 5.9% in active management group and 17.9% in physiological group (odds ratio 3.13; 95% confidence interval 2.3 to 4.2), a contrast reflected in other indices of blood loss. In physiological group third stage was longer (median 15 min v 5 min) and more women needed therapeutic oxytocics (29.7% v 6.4%). Apgar scores at one and five minutes and incidence of neonatal respiratory problems were not significantly different between groups. Babies in physiological group weighed mean of 85 g more than those in active group. When women allocated to and receiving active management (840) were compared with those who actually received physiological management (403) active management still produced lower rate of postpartum haemorrhage (odds ratio 2.4;95% CI1.6 to 3.7).
  
  
  CONCLUSIONS
  Policy of active management practised in this trial reduces incidence of postpartum haemorrhage, shortens third stage, and results in reduced neonatal packed cell volume.
authors.affiliation: Academic Department of Obstetrics and Gynaecology, Bristol Maternity Hospital, Avon.
authors.forename: W J
authors.initials: WJ
authors.lastname: Prendiville
authors.forename: J E
authors.initials: JE
authors.lastname: Harding
authors.forename: D R
authors.initials: DR
authors.lastname: Elbourne
authors.forename: G M
authors.initials: GM
authors.lastname: Stirrat
mesh_terms: D001942:Breast Feeding; D002986:Clinical Trials as Topic; D003250:Constriction; D036861:Delivery, Obstetric / Q000379:methods; D005260:Female; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007749:Labor Stage, Third; D007743:Labor, Obstetric; D007744:Obstetric Labor Complications / Q000628:therapy*; D010120:Oxytocics / Q000008:administration & dosage; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011187:Posture; D011247:Pregnancy; D011256:Pregnancy Outcome; D011897:Random Allocation; D013997:Time Factors; D014470:Umbilical Cord
chemical_list: D010120:Oxytocics